MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WEILAND, G.
Right arrow Articles by TAYLOR, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WEILAND, G.
Right arrow Articles by TAYLOR, P.

Molecular Pharmacology, Vol 15, 213-226, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Affinity Labeling of the Subunits of the Membrane Associated Cholinergic Receptor

GREGORY WEILAND 1, DENNIS FRISMAN 1, and PALMER TAYLOR 1

1 Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92093

Membranes enriched in acetylcholine receptor have been purified from Torpedo californica electric organs by gradient sedimentation and affinity partitioning. The preparations contain 40,000, 49,000, 60,000, 67,000 and 105,000 dalton peptides; the latter peptide can be virtually removed by the partitioning step. Two-dimensional electrophoresis reveals that the 67,000 and to a lesser extent the 49,000 dalton peptides exist as disulfide linked dimers. p-(Trimethylammonium) benzenediazonium fluoroborate (TDF), a structural analogue of phenyltrimethylammonium, binds covalently to the 40,000 and 105,000 dalton peptides present in the membrane fragments but only the labeling of the 40,000 dalton subunit is blocked by prior association of cholinergic agonists, antagonists and agr-toxin. The protectable labeling is saturable and stoichiometric with irreversibly blocked toxin sites; one molecule of [3H]TDF binds per toxin site. TDF thus appears to label specifically the ligand/toxin binding site of the receptor. Procedures which convert the receptor to its high affinity state for agonists such as prolonged incubation with agonist or short term incubation with agonist and local anesthetic enhance the extent of protection against irreversible labeling by TDF. Hence, covalent labeling by TDF appears to distinguish the two interconvertible receptor states identified previously in the membrane preparation by their different affinities for agonists.

Submitted on July 31, 1978
Accepted on October 16, 1978




This article has been cited by other articles:


Home page
ScienceHome page
N Fujita, N Nelson, T. Fox, T Claudio, J Lindstrom, H Riezman, and G. Hess
Biosynthesis of the Torpedo californica acetylcholine receptor alpha subunit in yeast
Science, March 14, 1986; 231(4743): 1284 - 1287.
[Abstract] [PDF]


Home page
ScienceHome page
J. Changeux, A Devillers-Thiery, and P Chemouilli
Acetylcholine receptor: an allosteric protein
Science, September 21, 1984; 225(4668): 1335 - 1345.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
J.-P. Changeux, F. Bon, J. Cartaud, A. Devillers-Thiery, J. Giraudat, T. Heidmann, B. Holton, H.-O. Nghiem, J.-L. Popot, R. Van Rapenbusch, et al.
Allosteric Properties of the Acetylcholine Receptor Protein from Torpedo marmorata
Cold Spring Harb Symp Quant Biol, January 1, 1983; 48(0): 35 - 52.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics